Ocugen (OCGN) Accounts Payables (2014 - 2026)
Ocugen's (OCGN) quarterly Accounts Payables came in at $3.2 million in Q1 2026, up 0.53% YoY from $3.2 million in Q1 2025, and down 47.74% on a QoQ basis from $6.2 million in Q4 2025.
Ocugen (OCGN) Accounts Payables (2014 - 2026) Analysis & Trends
Ocugen (OCGN) has 13 years of Accounts Payables data on file, last reported at $3.2 million in Q1 2026.
- Quarterly Accounts Payables rose 0.53% year-over-year to $3.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.2 million (up 0.53% YoY) and the FY2025 annual result came in at $6.2 million, up 46.17% from the prior year.
- Accounts Payables slipped to $3.2 million in Q1 2026, from $6.2 million in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $8.1 million in Q1 2023 to a low of $1.5 million in Q3 2024.
- A 5-year average of $4.4 million and a median of $3.9 million in 2022 frame the typical range for Accounts Payables.
- Annual changes were most pronounced in 2022 — Accounts Payables soared 638.28% — and 2024, when it plunged 78.61%.
- Tracing OCGN's Accounts Payables over 5 years: stood at $8.1 million in 2022, then slumped by 60.65% to $3.2 million in 2023, then surged by 33.76% to $4.2 million in 2024, then jumped by 46.17% to $6.2 million in 2025, then plunged by 47.74% to $3.2 million in 2026.
- The last three Accounts Payables figures came in at $3.2 million (Q1 2026), $6.2 million (Q4 2025), and $4.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Ocugen | 457.71 Mn | 357.61 Mn | - | 5.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.14 Mn |
| Mar 31, 2026 | 3.24 Mn |
| Dec 31, 2025 | 6.20 Mn |
| Sep 30, 2025 | 4.57 Mn |
| Jun 30, 2025 | 4.24 Mn |
| Mar 31, 2025 | 3.22 Mn |
| Dec 31, 2024 | 4.24 Mn |
| Sep 30, 2024 | 1.49 Mn |
| Jun 30, 2024 | 3.39 Mn |
| Mar 31, 2024 | 1.73 Mn |
| Dec 31, 2023 | 3.17 Mn |
| Sep 30, 2023 | 2.92 Mn |
| Jun 30, 2023 | 3.88 Mn |
| Mar 31, 2023 | 8.09 Mn |
| Dec 31, 2022 | 8.06 Mn |
| Sep 30, 2022 | 6.46 Mn |
| Jun 30, 2022 | 5.92 Mn |
| Mar 31, 2022 | 3.90 Mn |
| Dec 31, 2021 | 2.31 Mn |
| Sep 30, 2021 | 2.10 Mn |